Page 1575 - Small Animal Internal Medicine, 6th Edition

VetBooks.ir INDEX

A Acromegaly, feline (Continued) Acute lower motor neuron tetraparesis, Adulticides
A-a gradient. see Alveolar-arterial magnetic resonance imaging of, 750f 1166, 1167t for heartworm disease
gradient prognosis for, 753 Acute lung injury (ALI), 356 in cats, 206
ABCB1 gene, 1276 radiation therapy for, 753 Acute lymphoblastic leukemia, 1312t, in dogs, 199b, 200–201
Abdomen treatment of, 753 1313 pulmonary thromboembolic
distention of, 7f, 408–411, 410b Acrosomes, 946–947 Acute myelogenous leukemia, 1312t, complications, 201–203
enlargement of, 408–411, 410b Activated charcoal, 1185t–1186t 1313 Advantage. see Imidocloprid/moxidectin
radiographic imaging of, 419–420, Activated partial thromboplastin time, Acute myelomonocytic leukemia, 1312t Aelurostrongylus abstrusus
419f 228 Acute pancreatitis in airway washing, 1429f
Abdominal carcinomatosis, 513 Acute abdomen, 407–408, 408b, 409f analgesia for, 628–631, 629t–630t lower respiratory tract diseases caused
Abdominal effusion, 407, 519 Acute addisonian crisis, 886–888 antibiotics for, 633 by, 288–289, 297f, 297t
Abdominal hemangiosarcoma, 513 Acute bronchitis, 330b antiemetics for, 632–633 pulmonary parenchymal diseases
Abdominal pain, 408, 410b, 519 Acute canine polyradiculoneuritis biliary tract obstruction and, 633 caused by, 345
cranial, 625f–626f (ACP), 1166–1168, 1167t, 1168f in cats, 624f Aerobic infection, 1441t
Abdominal ultrasonography Acute diarrhea, 398–399, 398b, 474–476 chronic pancreatitis versus, 623t Afebrile neutropenia, 1279–1280, 1375
cancer staging using, 1288–1289 acute enteritis, 474–475 clinical features of, 621–625, 623t, 624f Aflatoxin, 598–599
hyperadrenocorticism evaluations, dietary-induced, 475–476 description of, 620 Agalactia, 978, 1034t–1036t
862–864, 862b, 863f–865f enterotoxemia and, 475 diagnosis of, 625–627 Agenesis, 1014
Abdominocentesis, 422, 543–544, 544t Acute enteritis, 474–475 diagnostic imaging of, 626–627, 627f Aggression, fear-induced, 975
Abducent nerve, 1055, 1056t Acute gastritis, 462 etiology of, 621, 623t Aglepristone, 960, 1034t–1036t
Abiotrophy, 1080–1081 Acute hemorrhagic diarrheal syndrome fluid analysis for, 627 Airway(s)
Abortifacient, 1034t–1036t (AHDS), 462–463, 482 gastroprotectants for, 633 extrathoracic, 380–381, 381f
Abortion, bacteria associated with, Acute hepatitis, 598–599, 598b histopathology of, 627 hydration of
965–966 Acute intervertebral disk disease intravenous fluids and electrolytes for, in bacterial pneumonia, 341b
Abscess, 612–613, 979f cervical disk extrusion, 1138t, 1139 628 nebulization for, 342
carnassial tooth root, 245–246 clinical features of, 1136, 1136f necrotizing, 628 intrathoracic, 381
epididymal, 1001f description of, 1135–1141 nutrition for, 631–632, 631b, 632f obstruction of, extrathoracic, 380–381
prostatitis with, 1003f diagnostic approach, 1136–1137, pancreatic enzyme assays, 625–626 suctioning of, 347
retrobulbar, 1124f 1137f–1139f pathogenesis of, 621, 623t treatment of, 347
splenic, 1412–1413 magnetic resonance imaging of, plasma transfusion for, 628 Albon. see Sulfadimethoxine
subcutaneous, site of glucose 1137 practice for feeding in, 631b Albuterol, 327b
administration, 1012f myelography for, 1137, 1138f prognosis for, 627–633 Aldosterone, 1363–1364
Absorption tests, 423 thoracolumbar disk extrusion, 1138t, prognostic factors of, 626 adrenal tumors that secrete, 892–893
Acanthocytosis, 1345t 1139–1141, 1140f, 1140t risk factors for, 623t physiologic effects of, 56–57
Acanthomatous ameloblastoma, 448t treatment of, 1137–1141 treatment of, 627–633 Aldosterone receptors, 56–57
Accelerated idioventricular rhythm, Acute kidney injury (AKI), 686–692 ultrasonography of, 627f Alendronate, 927, 934t
41 causes of, 687b Acute posterior paresis, 226 Alimentary lymphoma, 502–503, 1294,
Accessory nerve, 1056t chronic kidney disease versus, 687t Acute proctitis, 504 1309, 1496
Acepromazine, 19–20, 386t–388t, clinical findings of, 689 Acute respiratory distress syndrome Alimentary tract disease
733t–734t clinicopathologic findings of, 689–690 (ARDS), 356 diagnostic tests for, 412–431
hypertension treated with, 217t dialysis for, 692 Acute septic prostatitis, 1003 bacterial fecal culture, 414
neurologic disorders treated with, diuretics for, 691 Acute tubular necrosis, 687f barium contrast enemas, 423
1185t–1186t fluid administration for, 690 Acute tumor lysis syndrome, 1276, 1286, biopsy, 429–430
stress relief using, 380t hyperphosphatemia in, 691 1286f coagulation, 412
Acetamides, 1437t–1438t metabolic acidosis in, 691 Acute vestibular attacks, 1116 complete blood count, 412
Acetaminophen, 629t–630t nonsteroidal anti-inflammatory drugs Acute-phase proteins, 1420 contrast-enhanced gastrograms, 422
Acetazolamide, 1079–1080 as cause of, 686–687 Acute-phase reactants, 1420 contrast-enhanced studies, 422–423
Acetylcholine, 1041–1042 oliguria in, 688f Ad libitum feeding, 904–906 electron microscopy, 415
Acetylcholine receptors overhydration associated with, 692 Adenocarcinoma, 503 endoscopy, 424–429, 424f
antibodies to, 424 pathophysiology of, 686–689, intestinal, 503 enzyme-linked immunosorbent
myasthenia gravis caused by deficiency 687f–688f prostatic, 1003, 1003f assay, 399, 413
of, 1250 phases of, 687, 689f Adenoma(s) fecal digestion tests, 413–414
Acetylcholinesterase, 1041–1042 prognosis for, 692 hepatic cystadenoma, 575f fecal flotation, 413
Acetylsalicylic acid, 1197t, 1209t–1210t renal biopsy of, 690 macroadenoma, 749 IFA, 399, 414
Acholic feces, 529f treatment of, 690–692 parathyroid, 758–759, 759f laboratory evaluation routine,
Acid-base balance ultrasonographic findings, 690f thyroid, 800 412–413
blood gas analysis of, 318 Acute leukemias Adenosine triphosphatase pump, 931 other special tests for, 424
in Greyhounds, 1362, 1362t in cats, 1313t, 1319–1320 Adrenal cortex, 872f peritoneal fluid analysis, 423
Acquired chronic polyneuropathies, chemotherapy for, 1317b Adrenal gland, disorders of, 857–895 physical examination, 412
1164–1168 clinical features of, 1320 Adrenal insufficiency, primary, 888–889 polymerase chain reaction fecal
Acquired endocardial disease, 119–140 diagnosis of, 1320, 1320f Adrenal mass, incidental, 892–893, analysis, 414
Acquired esophageal weakness, 454–455, hematologic features of, 1320 893f–894f radiographs, 415
454f prevalence of, 1319–1320 Adrenal tumors serum biochemistry profile,
Acquired valvular disease, 119–140 treatment of, 1320 aldosterone-secreting, 892–893 405–406, 412–413
Acromegaly, feline, 749–753 in dogs, 1313–1316, 1313t cortisol-secreting, 875–876 serum cortisol, 413
clinical features of, 750–751, 751f chemotherapy for, 1317b progesterone-secreting, 893, 894f trypsin-like immunoreactivity,
clinical pathology of, 751–752 clinical features of, 1313, 1314f types of, 891t 413
clinical signs of, 750b diagnosis of, 1314–1316, 1316b Adrenalectomy, 875–876, 883 ultrasonography, 415
diagnosis of, 752, 752f hematologic features of, 1313–1314, α 1 -Adrenergic blockers, 217t, 218 urinalysis, 405–406, 413
etiology of, 749–750 1314f–1315f β-Adrenergic receptors, 93 tenesmus caused by, 403
hyperadrenocorticism versus, 752 prevalence of, 1313 Adrenocortical tumors, 857–858, 858f Alimentary tract parasites, 485–491
insulin-resistant diabetes mellitus remission of, 1316 Adrenocorticotropic hormone coccidiosis, 488
management in, 753 treatment of, 1316 endogenous concentration of, 866t, cryptosporidia, 488–489
871, 882 giardiasis, 489–490, 489f
stimulation test for, 866t, 870, 870f, heterobilharzia, 491
881t, 882, 885–886 hookworms, 487
Page numbers followed by “f ” indicate figures, “t” indicate tables, and “b” indicate boxes. Adriamycin. see Doxorubicin roundworms, 486–487, 486f
1547